Vox Sang. 2008 Jul;95(1):76-8. Epub 2008 Apr 2.

Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.

Lefrère JJ, Laperche S, Roudot-Thoraval F.

Source

Department of Blood-Transmissible Agents, National Institute of Blood Transfusion, Paris, France. jeanjacqueslefrere@orange.fr

Abstract

Being an orphan virus despite a large number of investigations, hepatitis G virus is a blood-borne agent for which screening is not required in blood donations. The in vivo efficacy of pathogen inactivation methods could be assessed by the absence of hepatitis G virus markers after transfusion of pathogen-inactivated blood products, in recipients susceptible to infection before the transfusion.

PMID:: 18393946; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Biological Markers

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Blood Transfusion and Donation - MedlinePlus Health Information

Supplemental Content

Related citations

Review Clinical trials for pathogen reduction in transfusion medicine: a review. [Transfus Apher Sci. 2009]
Review Clinical trials for pathogen reduction in transfusion medicine: a review.
McClaskey J, Xu M, Snyder EL, Tormey CA. Transfus Apher Sci. 2009 Dec; 41(3):217-25. Epub 2009 Sep 29.
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP]. [Transfus Clin Biol. 2009]
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP].
Naegelen C, Isola H, Dernis D, Maurel JP, Tardivel R, Bois S, Vignoli C, Cazenave JP. Transfus Clin Biol. 2009 May; 16(2):179-89. Epub 2009 May 13.
Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. [Transfusion. 2009]
Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Transfusion. 2009 Oct; 49(10):2214-20. Epub 2009 Jun 10.
Hepatitis G virus infection in multitransfused Egyptian children. [Pediatr Hematol Oncol. 2009]
Hepatitis G virus infection in multitransfused Egyptian children.
Salama KM, Selim Oel-S. Pediatr Hematol Oncol. 2009 Jun; 26(4):232-9.
Review Pathogen safety of plasma-derived products - Haemate P/Humate-P. [Haemophilia. 2008]
Review Pathogen safety of plasma-derived products - Haemate P/Humate-P.
Gröner A. Haemophilia. 2008 Nov; 14 Suppl 5:54-71.

See reviews... See all...

Cited by 1 PubMed Central article

Molecular Diagnostics in Transfusion Medicine: In Capillary, on a Chip, in Silico, or in Flight? [Transfus Med Hemother. 2009]
Molecular Diagnostics in Transfusion Medicine: In Capillary, on a Chip, in Silico, or in Flight?
Garritsen HS, Xiu-Cheng Fan A, Lenz D, Hannig H, Yan Zhong X, Geffers R, Lindenmaier W, Dittmar KE, Wörmann B. Transfus Med Hemother. 2009; 36(3):181-187. Epub 2009 May 18.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivati...
Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.
Vox Sang. 2008 Jul ;95(1):76-8. Epub 2008 Apr 2 .

PubMed
Acute liver failure of unknown pathogenesis: the hidden agenda.
Acute liver failure of unknown pathogenesis: the hidden agenda.
Hepatology. 1994 May ;19(5):1307-12.

PubMed
Genetic variations of the hepatitis B virus and their clinical relevance.
Genetic variations of the hepatitis B virus and their clinical relevance.
Microbiol Immunol. 1993 ;37(6):425-39.

PubMed
Isolation of the novel agent from human stool samples that is associated with sp...
Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis.
J Virol. 1994 Dec ;68(12):7810-5.

PubMed
Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infec...
Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site.
J Clin Invest. 2008 Feb ;118(2):801-11.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: